Determinants of BRAF mutations in primary melanomas

582Citations
Citations of this article
240Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

The RAS/mitogen-activated protein kinase pathway sends external growth-promoting signals to the nucleus. BRAF, a critical serine/threonine kinase in this pathway, is frequently activated by somatic mutation in melanoma. Using a cohort of 115 patients with primary invasive melanomas, we show that BRAF mutations are statistically significantly more common in melanomas occurring on skin subject to intermittent sun exposure than elsewhere (23 of 43 patients; P

Cite

CITATION STYLE

APA

Maldonado, J. L., Fridlyand, J., Patel, H., Jain, A. N., Busam, K., Kageshita, T., … Bastian, B. C. (2003). Determinants of BRAF mutations in primary melanomas. Journal of the National Cancer Institute, 95(24), 1878–1880. https://doi.org/10.1093/jnci/djg123

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free